Shane Cooke

Shane Cooke joined Etiometry in 2019 as president and CEO, bringing over 20 years of experience in the medical device and pharmaceutical market spaces in a variety of sales, marketing, strategy and portfolio management roles. Before joining Etiometry, Shane spent more than five years as chief strategy officer of Cheetah Medical, which was acquired by Baxter International in 2019. Prior to Cheetah, Shane spent 11 years with Covidien in the patient care, vascular therapies and corporate sectors, with positions such as: corporate strategy, market and competitive intelligence, leading the market development center of excellence and leading strategy efforts for Japan, Europe, Australia and Canada. Shane holds a BA in psychology from the University of Rochester, as well as an MBA from Suffolk University.

Posts by Shane Cooke

MedCity Influencers

Leveraging AI and LLMs To Close Critical Gaps in Patient Data and Transform Patient Risk Assessment in the ICU

It is our obligation to do our part to find ways to improve patient outcomes and lower health care costs. This often means continuously finding better, more efficient ways to solve problems, utilizing the most optimal tools and data we have at our disposal. And as of right now, and for the foreseeable future, that means finding appropriate use cases to leverage the power of AI and LLMs where it most makes sense.